
Katharine Phillips, MD
Professor of Psychiatry
Weill Cornell Medical College

Assessment and Treatment of Body Dysmorphic Disorder
Thursday, February 11, 2027
3:45 PM - 4:45 PM
Katharine A. Phillips, M.D., is Professor of Psychiatry, DeWitt Wallace Senior Scholar, and Research Director for the Psychiatry Residency at Weill Cornell Medical College in New York City. She is also Attending Psychiatrist at New York-Presbyterian Hospital. Dr. Phillips graduated with honors from Dartmouth College and Dartmouth Medical School, and she completed her psychiatry residency at McLean Hospital/Harvard Medical School. Dr. Phillips is internationally recognized for her research studies and clinical expertise in body dysmorphic disorder (BDD).
Her research studies on BDD were continuously funded by the National Institute of Mental Health for more than 20 years. Her groundbreaking work has included identification of BDD’s clinical features and morbidity, BDD in cosmetic treatment settings, and development of screening, diagnostic, severity, and insight measures. She has published most of the medication studies of BDD, and she co-developed and tested the efficacy of cognitive-behavioral therapy for BDD. Dr. Phillips has more than 380 publications in scientific journals and books, and she has authored or edited 11 books, including multiple books on BDD. Dr. Phillips has given more than 675 presentations around the world. She has received many honors and awards for her research, clinical work, and other academic contributions. Her awards for her research studies on BDD include a Special Presidential Commendation from the American Psychiatric Association and the 2023 Outstanding Career Achievement Award from the International OCD Foundation.
Lecture Summary:
This presentation will review the prevalence, clinical features, assessment, and treatment of body dysmorphic disorder (BDD), an often underrecognized condition associated with significant distress and impairment. The session will examine key diagnostic features, morbidity, and relevant research findings to support improved recognition in clinical practice. It will also review evidence-based treatment approaches, including pharmacotherapy and cognitive-behavioral therapy, with practical guidance on how these interventions can be implemented effectively.
Goals and Learning Objectives:
-
Objective 1 : To describe research findings on key features of body dysmorphic disorder, including prevalence, clinical features, morbidity, and neurobiology.
-
Objective 2 : To demonstrate ability to recognize and diagnose body dysmorphic disorder.
-
Objective 3 : To describe evidence-based treatment strategies for body dysmorphic disorder, including pharmacologic approaches and cognitive-behavioral approaches.
Disclosures:
Speakers' Bureau or Honoraria : Merck Manual, BMJ Best Practice,The Anxiety Center for Children and Adolescents (Litla Kvíðameðferðarstöðin), American Academy of Cosmetic Surgery, American Society of Ophthalmic Plastic and Reconstructive Surgery, academic institutions
Royalty : Wolter's Kluwar (UpToDate), Oxford University Press, Creative Artists Agency, Guilford Publications, American Psychiatric Association Publishing
Intellectual Property Rights : Proem Health (NView), OCD Scales
.png)